BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 32317519)

  • 41. [Association of peripheral nerve invasion with clinicopathological factors and prognosis of colorectal cancer].
    Han D; Wei Y; Wang X; Wang G; Chen Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):62-66. PubMed ID: 28105622
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of non-schistosomal colorectal cancer and schistosomal colorectal cancer.
    Wang W; Lu K; Wang L; Jing H; Pan W; Huang S; Xu Y; Bu D; Cheng M; Liu J; Liu J; Shen W; Zhang Y; Yao J; Zhu T
    World J Surg Oncol; 2020 Jul; 18(1):149. PubMed ID: 32611359
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Apical Lymph Nodes in the Distant Metastases and Prognosis of Patients with Stage III Colorectal Cancer with Adequate Lymph Node Retrieval Following FOLFOX Adjuvant Chemotherapy.
    Tsai HL; Chen YT; Yeh YS; Huang CW; Ma CJ; Wang JY
    Pathol Oncol Res; 2019 Jul; 25(3):905-913. PubMed ID: 29299827
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic significance of high mobility group box 1 (HMGB1) expression in patients with colorectal cancer.
    Ueda M; Takahashi Y; Shinden Y; Sakimura S; Hirata H; Uchi R; Takano Y; Kurashige J; Iguchi T; Eguchi H; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K
    Anticancer Res; 2014 Oct; 34(10):5357-62. PubMed ID: 25275029
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Loss of EphB6 protein expression in human colorectal cancer correlates with poor prognosis.
    Peng L; Tu P; Wang X; Shi S; Zhou X; Wang J
    J Mol Histol; 2014 Oct; 45(5):555-63. PubMed ID: 24912672
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of early growth response-1 in colorectal cancer and its relation to tumor cell proliferation and apoptosis.
    Myung DS; Park YL; Kim N; Chung CY; Park HC; Kim JS; Cho SB; Lee WS; Lee JH; Joo YE
    Oncol Rep; 2014 Feb; 31(2):788-94. PubMed ID: 24297681
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lymph node yield after colectomy for cancer: is absence of mismatch repair a factor?
    Samdani T; Schultheis M; Stadler Z; Shia J; Fancher T; Misholy J; Weiser MR; Nash GM
    Dis Colon Rectum; 2015 Mar; 58(3):288-93. PubMed ID: 25664706
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proteomic profiling of proteins associated with lymph node metastasis in colorectal cancer.
    Ma Y; Zhao M; Zhong J; Shi L; Luo Q; Liu J; Wang J; Yuan X; Huang C
    J Cell Biochem; 2010 Aug; 110(6):1512-9. PubMed ID: 20524204
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Loss of SDC1 Expression Is Associated with Poor Prognosis of Colorectal Cancer Patients in Northern China.
    Li K; Li L; Wu X; Yu J; Ma H; Zhang R; Li Y; Wang W
    Dis Markers; 2019; 2019():3768708. PubMed ID: 31182980
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum vascular endothelial growth factor-C and lymphoangiogenesis are associated with the lymph node metastasis and prognosis of patients with colorectal cancer.
    Wang TB; Chen ZG; Wei XQ; Wei B; Dong WG
    ANZ J Surg; 2011 Oct; 81(10):694-9. PubMed ID: 22295309
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MicroRNA-7 Is Associated with Malignant Potential and Poor Prognosis in Human Colorectal Cancer.
    Nagano Y; Toiyama Y; Okugawa Y; Imaoka H; Fujikawa H; Yasuda H; Yoshiyama S; Hiro J; Kobayashi M; Ohi M; Araki T; Inoue Y; Mohri Y; Kusunoki M
    Anticancer Res; 2016 Dec; 36(12):6521-6526. PubMed ID: 27919977
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diffuse expression of RNA-binding protein IMP3 predicts high-stage lymph node metastasis and poor prognosis in colorectal adenocarcinoma.
    Yuan RH; Wang CC; Chou CC; Chang KJ; Lee PH; Jeng YM
    Ann Surg Oncol; 2009 Jun; 16(6):1711-9. PubMed ID: 19357927
    [TBL] [Abstract][Full Text] [Related]  

  • 53. IMP3 expression in biopsy specimens of colorectal cancer predicts lymph node metastasis and TNM stage.
    Wei Q; Huang X; Fu B; Liu J; Zhong L; Yang Q; Zhao T
    Int J Clin Exp Pathol; 2015; 8(9):11024-32. PubMed ID: 26617820
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Location of early colorectal cancers at fold-top may reduce the risk of lymph node metastasis.
    Pan W; Terai T; Abe S; Sakamoto N; Nagahara A; Ohkusa T; Ogihara T; Sato N
    Dis Colon Rectum; 2006 May; 49(5):579-87. PubMed ID: 16583291
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reduced p16 expression correlates with lymphatic invasion in colorectal cancers.
    Tada T; Watanabe T; Kazama S; Kanazawa T; Hata K; Komuro Y; Nagawa H
    Hepatogastroenterology; 2003; 50(54):1756-60. PubMed ID: 14696398
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
    Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
    Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SIRT2, a direct target of miR-212-5p, suppresses the proliferation and metastasis of colorectal cancer cells.
    Du F; Li Z; Zhang G; Shaoyan S; Geng D; Tao Z; Qiu K; Liu S; Zhou Y; Zhang Y; Gu J; Wang G; Li L; Wu W
    J Cell Mol Med; 2020 Sep; 24(17):9985-9998. PubMed ID: 32697380
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression.
    Zlobec I; Baker K; Minoo P; Jass JR; Terracciano L; Lugli A
    Clin Cancer Res; 2008 Jan; 14(1):143-8. PubMed ID: 18172264
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Over-expression of Nav1.6 channels is associated with lymph node metastases in colorectal cancer.
    Lin S; Lv Y; Xu J; Mao X; Chen Z; Lu W
    World J Surg Oncol; 2019 Oct; 17(1):175. PubMed ID: 31672162
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proteomics analysis of differential protein expression identifies heat shock protein 47 as a predictive marker for lymph node metastasis in patients with colorectal cancer.
    Mori K; Toiyama Y; Otake K; Fujikawa H; Saigusa S; Hiro J; Kobayashi M; Ohi M; Tanaka K; Inoue Y; Kobayashi Y; Kobayashi I; Mohri Y; Goel A; Kusunoki M
    Int J Cancer; 2017 Mar; 140(6):1425-1435. PubMed ID: 27925182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.